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ABSTRACT Viroporins are viral proteins with ion channel (IC) activity that play an
important role in several processes, including virus replication and pathogenesis.
While many coronaviruses (CoVs) encode two viroporins, severe acute respiratory
syndrome CoV (SARS-CoV) encodes three: proteins 3a, E, and 8a. Additionally, pro-
teins 3a and E have a PDZ-binding motif (PBM), which can potentially bind over 400
cellular proteins which contain a PDZ domain, making them potentially important
for the control of cell function. In the present work, a comparative study of the
functional motifs included within the SARS-CoV viroporins was performed, mostly fo-
cusing on the roles of the IC and PBM of E and 3a proteins. Our results showed that
the full-length E and 3a proteins were required for maximal SARS-CoV replication
and virulence, whereas viroporin 8a had only a minor impact on these activities. A
virus missing both the E and 3a proteins was not viable, whereas the presence of ei-
ther protein with a functional PBM restored virus viability. E protein IC activity and
the presence of its PBM were necessary for virulence in mice. In contrast, the pres-
ence or absence of the homologous motifs in protein 3a did not inﬂuence virus
pathogenicity. Therefore, dominance of the IC and PBM of protein E over those of
protein 3a was demonstrated in the induction of pathogenesis in mice.
IMPORTANCE Collectively, these results demonstrate key roles for the ion channel
and PBM domains in optimal virus replication and pathogenesis and suggest that
the viral viroporins and PBMs are suitable targets for antiviral therapy and for muta-
tion in attenuated SARS-CoV vaccines.
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Coronaviruses (CoVs) are pathogens responsible for a wide range of existing andemerging diseases in humans and domestic or companion animals (1). A CoV
causing the severe acute respiratory syndrome (SARS-CoV) was identiﬁed in Southeast
China in 2002 and rapidly spread worldwide to more than 30 countries within
6 months, infecting more than 8,000 people, with mortality in approximately 10% of the
cases (2, 3). While SARS-CoV has not since reappeared in humans, other CoVs, including
ones similar to SARS-CoV, are widely disseminated among bats circulating all over the
world, making future outbreaks possible (4–6). In fact, a novel CoV, the Middle East
respiratory syndrome coronavirus (MERS-CoV), was identiﬁed in September 2012 in two
human patients with severe respiratory disease in Saudi Arabia (7, 8); since then, the
WHO has reported 2,144 laboratory-conﬁrmed cases and at least 750 deaths (as of
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29 March 2018) (http://www.who.int/emergencies/mers-cov/en/). These data indicate
that emergence of other highly pathogenic CoVs is likely and thus that the study of the
virus-host interaction is essential to develop antiviral therapies and safe vaccines.
Viroporins constitute a large class of multifunctional viral proteins with ion channel
(IC) activity that are widely distributed among different viral families (9); highly patho-
genic human viruses such as human immunodeﬁciency virus 1 (HIV-1), hepatitis C virus
(HCV), inﬂuenza A virus (IAV), rotavirus (RV), enterovirus, and CoVs such as SARS-CoV
and MERS-CoV encode them (10–16). Viroporins promote several steps of the virus
replication cycle, including entry, genome replication, morphogenesis, and release from
the infected cell (17, 18). Several viroporins have important roles in viral pathogenesis,
promoting ion imbalances within cells (13, 19–21) or disrupting cellular pathways
through protein-protein interactions (22). Given their potential as antiviral targets, there
is substantial interest in the study of these proteins (18, 23).
Several CoVs, such as MERS-CoV, HCoV-229E, HCoV-OC43, and porcine epidemic
diarrhea virus (PEDV), encode two viroporins (24–26), but, remarkably, SARS-CoV en-
codes three: proteins 3a, E, and 8a (14, 27, 28). The 3a protein is 274 amino acids (aa)
in length with three transmembrane domains (TMDs). It is the largest SARS-CoV
accessory protein and is likely involved in virus release (27) and pathogenesis (29). It
causes membrane rearrangements in infected cells, leading to an increase in levels of
intracellular vesicles that may facilitate nonlytic release of viral particles (30). Further-
more, it colocalizes with M protein, which, together with E protein, is essential for virus
assembly, supporting the notion that the 3a protein is important for SARS-CoV assem-
bly or budding (31, 32). However, most studies have been based on 3a overexpression
and little is known about the relevance of this protein in the context of natural
infection.
SARS-CoV E protein is an integral membrane protein of 76 aa with only one TMD.
The residues responsible for E protein IC activity have been previously identiﬁed (33,
34). E protein IC activity is important for SARS-CoV ﬁtness and pathogenesis, since both
were diminished in its absence (34).
The 8a protein found in SARS-CoV-infected human cells resulted from a 29-
nucleotide (nt) deletion in open reading frame 8 (ORF8) that occurred after the virus
crossed species to infect humans (35). ORF8 genes encode two proteins, ORF8a and
ORF8b, which represent proteins of 39 and 84 aa, respectively. Overexpression assays
showed that ORF8a induces apoptosis through a mitochondrion-dependent pathway
(36) and has IC activity (28).
Viroporins and cellular IC proteins often rely on protein-protein interactions for
clustering of ICs at proper locations in the cell (37–39). These interactions are mediated
between PDZ domains and PDZ-binding motifs (PBMs), peptide sequences that are
most frequently located at the C terminus of the IC proteins (40, 41). PDZ domains are
protein recognition sequences, 80 to 90 aa in length, and constitute a large family of
globular domains found in prokaryotes and eukaryotes. There are more than 400
cellular protein isoforms containing a PDZ domain in the human proteome (42). The
PBM core sequence includes 4-aa residues, numbered from the C terminus (p0), which
is always hydrophobic, to the N terminus (p-1, p-2, and p-3). There are three classes of
PBMs, depending on the identity of residue p-2: class I for Thr/Ser, class II for any
hydrophobic residue, and class III for Glu/Asp. Protein-protein interactions involving
PDZ domains modulate cellular pathways important for viral replication, dissemination
in the host, and pathogenesis (43). Furthermore, some PDZs also bind PBMs located in
the internal region of proteins or lipids (44, 45). Of the three SARS-CoV viroporins, both
proteins 3a and E have a class II PBM at their C terminus; while the PBM of E protein is
involved in pathogenesis (46, 47), the role of the PBM of protein 3a, and of similar
motifs present in other CoV proteins such as MERS-CoV proteins E and 5, remains
unknown.
In the present work, using mutational analysis, we showed that only the 3a and E
proteins were clearly involved in SARS-CoV replication and virulence. Neither single
deletion of the IC activity or of PBM from protein 3a diminished SARS-CoV replication
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and virulence, in contrast with E protein, which required both for virulence (34, 46).
Protein 3a IC activity was characterized in planar lipid bilayers, showing that it forms
non-voltage-gated ion channels. Furthermore, we identiﬁed residues located in TMD2
and TMD3 of the 3a protein that were involved in its IC activity. The potential
interdependence of the three viroporins described in SARS-CoV was studied by dele-
tion of single viroporins or of different combinations of two viroporins. The variant
missing both the 3a and E proteins was not viable, indicating that the presence of at
least one of the proteins is essential for virus viability. Furthermore, it was shown that
either protein should maintain its PBM to compensate for the absence of the other
full-length protein. These results suggest that PBMs interact with cellular proteins with
PDZ domains to change cell metabolism, enhancing virus replication or pathogenicity.
Identiﬁcation and inhibition of speciﬁc cellular pathways affected by these interactions
may be crucial for the identiﬁcation of new antiviral strategies.
RESULTS
SARS-CoV viroporins E and 3a were required for efﬁcient replication in vitro
and in vivo. To study the role of the SARS-CoV viroporins in virus replication and
virulence, three mutant viruses, each lacking one gene (recombinant SARS [rSARS]-
CoV-MA15-Δ3a, -ΔE, and -Δ8a), were engineered from a mouse-adapted infectious
cDNA clone (MA15) (48, 49). Analysis of the growth kinetics of each mutant in Vero E6
cell supernatants (Fig. 1A) was used to determine their requirement for replication.
Cell-associated virus was also analyzed at 24 and 48 h postinfection (hpi), showing
results similar to those observed for the released virus (see Fig. S1 in the supplemental
material). The Δ3a and ΔE mutants grew to lower titers than the parental wild-type (wt)
virus (Fig. 1A). However, while the ΔE mutant showed 100-fold-lower titers (around 8
105 PFU/ml), Δ3a titers decreased slightly (3-fold) (3  107 PFU/ml). These results show
that both proteins were required for optimal virus replication in cell culture. In contrast,
the Δ8a virus reached peak titers (9  107 PFU/ml) similar to those observed for the
parental virus.
To evaluate the requirement for protein 3a, E, or 8a for optimal virus growth in vivo,
BALB/c mice were infected either with rSARS-CoV-MA15 or with each of the viroporin
deletion mutants SARS-CoV-MA15-Δ3a, -ΔE, and -Δ8a, and viral titers in lungs were
determined at 2 and 4 days postinfection (dpi) (Fig. 1B). The highest titers were reached
at 2 dpi, and the titers decreased in all cases by between 5-fold and 40-fold at 4 dpi,
with the parental and Δ8a viruses achieving the highest titers in lung tissue (around
108 PFU/g at 2 dpi and 2  107 PFU/g at 4 dpi). However, compared to the parental
virus, titers were reduced by 1 and 2 log units in the case of Δ3a and ΔE virus,
respectively. Interestingly, the decrease in virus titers after SARS-CoV-MA15-Δ3a infec-
tion was greater in vivo than in vitro. Thus, proteins E and 3a were shown to be critical
for both in vitro and in vivo virus replication.
SARS-CoV viroporins E and 3a were both associated with virulence in a mouse
model. To evaluate the relevance of SARS-CoV E, 3a, and 8a viroporins for virulence,
BALB/c mice were either subjected to mock infection or infected with parental rSARS-
CoV-MA15 or with one of the deletion mutants rSARS-CoV-MA15-Δ3a, -ΔE, and -Δ8a.
Clinical disease and survival were monitored through 10 dpi (Fig. 2). Mice infected with
viruses lacking either E protein or 3a protein recovered from infection with 100%
survival, although mice infected with the Δ3a virus showed mild disease symptoms. In
contrast, mice infected with the parental virus or the Δ8a virus developed manifesta-
tions of serious disease (lethargy and rufﬂed fur) starting from 2 dpi. These mice all died
by 6 dpi, clearly showing that both E and 3a proteins were involved in SARS-CoV
virulence in the mouse model, while 8a did not seem to play a major role.
Characterization of the IC activity of protein 3a in planar lipid bilayers. The IC
activity of protein E is required for SARS-CoV replication and virulence (34). However, as
the relevance of the IC activity of the 3a protein was not known, we studied 3a protein
in planar lipid bilayers and identiﬁed the amino acids involved in ion conductance. This
system was used because its high sensitivity allows the detection of electric currents of
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a single ion channel (50). To this end, a baculovirus was engineered to express the
parental 3a protein in Sf-9 cells. Conductance of puriﬁed protein 3a was evaluated in
the presence of KCl in planar lipid bilayers with a biologically relevant mix of
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)/1,2-dioleoyl-sn-glycero-3-phospho-
L-serine (DOPS)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) with ratios of
3:1:1 (wt/wt), which is a composition similar to that of intracellular organelle mem-
branes, such as the endoplasmic reticulum (ER)-Golgi intermediate compartment (ER-
GIC). Single-channel conductance was estimated from a statistical analysis of the
current jump amplitudes. This procedure allows a reliable estimate of the most prob-
able value of current change every time a new channel is inserted or disappears.
Although several channels were being inserted, the magnitude of the current through
a single channel could be discriminated. Current jumps corresponding to 201 inde-
FIG 1 Growth kinetics of SARS-CoV viroporin-defective mutants. (A) Subconﬂuent monolayers of Vero E6
cells were infected with wild-type (WT) (black ﬁlled circles), ΔE (blue ﬁlled squares), Δ3a (red ﬁlled circles),
and Δ8a (green ﬁlled diamonds) SARS-CoV at a MOI of 0.001. Culture supernatants were collected at 4,
24, 48, and 72 hpi and titrated by plaque assay. The results are representative of three replicate
experiments. (B) Groups of six 16-week-old BALB/c mice were infected with 100,000 PFU of either the
parental virus (WT, black columns) or genetically engineered viruses lacking E protein (ΔE, blue columns),
3a protein (Δ3a, red columns), or 8a protein (Δ8a, green columns). At 2 and 4 dpi, 3 mice from each group
were sacriﬁced to determine lung virus titers. Data summarize two replicate experiments. Data represent
means  standard deviations (SD). *, P value 0.1; **, P value 0.01; ***, P value 0.001.
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pendent events were measured under conditions of an applied voltage of 100 mV.
Histograms of the current jump amplitudes of the recorded traces showed that the
most frequent events corresponded to single-channel conductance of 16 pA (Fig. 3A
and B). Simultaneous bursts of two or three 3a ion channels were also observed,
although with much lower frequency (Fig. 3B).
To test if 3a behaves as a voltage-gated IC, its activity was also measured in planar
lipid bilayers under conditions of different voltages in the presence of monovalent
(NaCl) and divalent (CaCl2) cations (Fig. 3C). In all cases, a linear current-voltage (I-V)
relationship was obtained, demonstrating that the channel displayed resistance (ohmic)
behavior for both positive and negative potential. These results indicate that the
protein 3a IC was neither open nor closed at speciﬁc electric potentials.
Measurement of the reversal potential (Erev) of an ion channel, which is deﬁned as
the voltage that needs to be applied to yield zero electric current when there is an ion
concentration gradient across the membrane, is the method of choice to quantify ion
selectivity. Determination of the sign of the Erev provides a quick estimation of the
channel selectivity, that is, of its preference for cations or anions (51, 52). By comparing
the measured Erev to the theoretical Erev that would be obtained in the case of a neutral
pore (i.e., representing only the difference between cation and anion intrinsic mobili-
ties), the selectivity of the ion channel can be inferred. The theoretical Erev is calculated
using the Goldman-Hodgkin-Katz (GHK) equation, replacing the permeability ratio
P/P by the solution diffusion coefﬁcient ratio D/D (53). Higher, lower, or similar
measured Erev values indicate anion selectivity, cation selectivity, or no selectivity,
respectively. Interestingly, in the presence of monovalent ions (Na and K), the
protein 3a IC showed weak cation selectivity. However, in the presence of Ca, the
channel behaved as a neutral channel with no preference for anions or cations
(Table 1). Taken together, these results indicated that at least Na, K, and Ca were
conducted through the 3a protein IC.
Identiﬁcation of amino acids involved in protein 3a IC activity. In order to
identify the amino acids necessary for protein 3a IC activity, a set of recombinant
baculoviruses (rBV) expressing mutated 3a proteins was engineered. Amino acid sub-
stitutions were created to disrupt the IC activity of 3a with minimal impact on its
three-dimensional structure, mutating residues predicted to face the lumen of the pore.
As the 3a protein structure has not yet been experimentally determined, in silico
models were used to select the residues potentially facing the lumen of the pore (54,
55). As the 3a protein has three TMDs, mutants with changes to a single TMD (TMD1,
TMD2, or TMD3) or to two TMDs (TMD[2,3]) were engineered (Table 2). Mutant 3a
FIG 2 Virulence of SARS-CoV viroporin-defective mutants. Groups of ﬁve 16-week-old BALB/c mice were
subjected to mock infection (PBS, gray ﬁlled circles) or infected with 100,000 PFU of either the parental virus (wt,
black ﬁlled circles) or genetically engineered viruses missing E protein (ΔE, blue ﬁlled squares), 3a protein (Δ3a,
red ﬁlled circles), or 8a protein (Δ8a, green ﬁlled diamonds). Mean levels of weight loss (left graph) and survival
(right graph) through 10 dpi are shown for each group. Data summarize two replicate experiments with
equivalent results. Error bars represent the standard deviations of mouse weight data.
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proteins were expressed in insect cells and puriﬁed, and their IC activity was evaluated
in planar lipid bilayers (Fig. 4). The TMD1 mutant retained IC activity, but the TMD2,
TMD3, and TMD[2,3] variants did not, consistent with the importance of TMD2 and
TMD3, as predicted by in silico models (54, 55).
FIG 3 Characterization of the SARS-CoV 3a protein ion channel. (A) Recording of a single-channel insertion of SARS-CoV
3a protein. (B) Histogram of current jump amplitude (right) at 100 mV in 500 mM KCl, composed of values from 201
recording events. (C) SARS-CoV 3a protein voltage-independent ion channel. The 3a protein showed a linear current-voltage
relationship. Displayed data correspond to representative I-V plots from reversal potential experiments performed with
500/50 mM solutions of monovalent (NaCl, red ﬁlled squares) and divalent (CaCl2, blue ﬁlled triangles) cations. Each
experiment was performed at least three times; the lines represent linear regression ﬁts of data points.
TABLE 1 Results of protein 3a reversal potential experiments performed with 500/50 mM
salt solutions
Ion solution
Erev (mV)a
Experimental Reference
NaCl 19.1  14.8 8.86
KCl 13.0  4.0 0.73
CaCl2 18.8  6.0 20.3
aExperimental reversal potential (Erev) values represent the averages of results from at least 7 independent
experiments. Reference Erev values represent theoretical values for a neutral pore.
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To resolve the exact residues necessary for protein 3a IC activity, a complementary
set of baculoviruses incorporating single amino acid substitutions within mutants
TMD2 (Y91A and H93A) and TMD3 (Y109A, Y113A, and Q116A) was generated. These
mutant proteins were expressed and puriﬁed, and their IC activity was evaluated. TMD2
point mutants Y91A and H93A and TMD3 point mutant Y109A completely abrogated
protein 3a IC activity, whereas TMD3 point mutants Y113 and Q116 showed conduc-
tance that was equivalent to and only moderately decreased from that seen with the
wt protein, respectively. Therefore, these results identiﬁed 3 amino acids that could be
mutated to eliminate protein 3a IC activity.
Protein 3a IC activity was not required for SARS-CoV replication and virulence.
To study the relevance of protein 3a IC activity in virus replication and virulence, the
following collection of full-length rSARS-CoVs with and without protein 3a IC activity
was generated by introducing speciﬁc mutations into the 3a gene: rSARS-CoV-MA15-
3a-TMD1, -TMD2, -TMD3, -TMD[2,3], -Y91A, -H93A, -Y109A, -Y113A, and -Q116A.
All these viruses were similar with respect to growth kinetics in Vero E6 cells (Fig. 5A),
indicating that replication was not signiﬁcantly affected by altered protein 3a IC activity.
The requirement for protein 3a IC activity in vivo was also studied by measuring the
titers of 3a IC mutants in the lungs of infected BALB/c mice at 2 and 4 dpi (Fig. 5B). Peak
titers were reached at 2 dpi and had decreased by around 1 log unit at 4 dpi in all cases.
Every mutant showed replication levels similar to those seen with the wt strain (around
1  107 PFU/g of lung tissue at 2 dpi and 4  106 PFU/g at 4 dpi), with the exception
TABLE 2 3a protein ion channel mutations
Mutant Mutations
TMD1 S40A, S58A
TMD2 Y91A, H93A
TMD3 Y109A, Y113A, Q116A
TMD[2,3] Y91A, H93A, Y109A, Y113A, Q116A
FIG 4 Effect of mutations on the ion channel activity of SARS-CoV 3a protein. Recombinant 3a protein
variants were reconstituted in artiﬁcial lipid bilayers, and their IC activity was tested in 500 mM KCl
solutions. Mean conductance values were measured for variants showing IC activity. Negative control
(C) data indicate conductance values obtained in the absence of any protein; error bars represent the
standard deviations of data obtained in at least 100 independent measurements.
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of TMD3, which had titers at least 1 log unit lower than those seen with the rest of the
viruses (3  106 PFU/g at 2 dpi and 1  104 PFU/g at 4 dpi) (Fig. 5B). These results
indicated that protein 3a IC activity was not essential for SARS-CoV replication in mouse
lungs.
The requirement of protein 3a IC activity for SARS-CoV virulence was studied in two
independent experiments. In the ﬁrst, BALB/c mice were infected with rSARS-CoV-MA15
(virulent virus control), rSARS-CoV-MA15-Δ3a (attenuated virus control), or one of the
rSARS-CoV mutants TMD1, TMD2, TMD3, and TMD[2,3] (Fig. 6A), with clinical
FIG 5 Growth kinetics of SARS-CoV mutants targeting 3a protein ion channel activity. (A) Subconﬂuent
monolayers of Vero E6 cells were infected at a MOI of 0.001 with wild-type SARS-CoV (WT, black ﬁlled
circles) or with variants with mutations affecting 3a protein TMD1 (TMD1-, light green ﬁlled circles), TMD2
(TMD2-, light blue ﬁlled triangles), TMD3 (TMD3-, ochre ﬁlled triangles), or both TMD2 and TMD3
(TMD[2,3]-, light brown ﬁlled triangles) or residue Y91 (Y91A, purple ﬁlled diamonds), residue H93 (H93A,
deep blue ﬁlled diamonds), residue Y109 (Y109A, orange ﬁlled diamonds), residue Y113 (Y113A, dark
brown ﬁlled diamonds), or residue Q116 (Q116A, red ﬁlled diamonds). Culture supernatants collected at
4, 24, 48, and 72 hpi were titrated by plaque assay. Results are representative of three replicate
experiments. For the sake of clarity, SD data are not shown but the values were, in all cases, lower than
5%. (B) Groups of six 16-week-old BALB/c mice were infected with 100,000 PFU of either the parental
virus (WT, black columns), or mutants TMD1 (light green columns), TMD2 (light blue columns), TMD3
(ochre columns), TMD[2,3] (light brown columns), Y91A (purple columns), H93A (deep blue columns),
Y109A (orange columns), Y113A (dark brown columns), and Q116A (red columns). At 2 and 4 dpi, 3 mice
from each group were sacriﬁced to determine virus titers. Data summarize two replicate experiments.
Data represent means  SD. *, P value 0.1; **, P value 0.01; ***, P value 0.001.
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disease and survival evaluated for 10 days. All mice infected with the parental virus or
the TMD1 mutant showed disease symptoms starting at 2 dpi, and all died at 5 or
7 dpi, respectively. Mice infected with the TMD2 mutant showed acute disease
starting at 2 dpi, and 80% of the mice had died by between 4 and 7 dpi. In contrast,
mice infected with either TMD3 or TMD[2,3] mutants recovered from the disease
with 100% survival, similarly to mice infected with the attenuated SARS-CoV-Δ3a
variant (Fig. 6A). During the experiment, viruses were recovered from the lungs of
moribund mice, and the 3a gene was sequenced. No compensatory mutations restor-
ing IC activity were identiﬁed in any case. The results suggest that the TMD3 and
TMD[2,3] mutants were attenuated in an IC-independent manner, since the TMD2
mutant was only marginally attenuated.
In the second virulence experiment, mice were infected with rSARS-CoV incorpo-
rating protein 3a point mutations (Y91A, H93A, Y109A, Y113A, and Q116A), with the
parental and Δ3a variants serving as virulent and attenuated controls, respectively. All
of the 3a point mutants caused severe disease with 100% mortality by 6 dpi, similarly
to mice infected with the wt parent and in contrast to those infected with the Δ3a
variant, which survived (Fig. 6B). No compensatory mutations restoring IC activity were
identiﬁed in this experiment, further conﬁrming that protein 3a IC activity was not
essential for SARS-CoV virulence in the mouse model used.
FIG 6 Virulence of SARS-CoV 3a ion channel mutants. Groups of ﬁve 16-week-old BALB/c mice were
subjected to mock infection (PBS, gray ﬁlled squares) or infected with 100,000 PFU of the parental virus (WT,
black hexagons) or with genetically engineered mutants lacking the 3a protein (Δ3a, dark green ﬁlled
circles), and (A) mutants with altered TMD1 (TMD1, light green ﬁlled circles), TMD2 (TMD2, light blue
ﬁlled diamonds), TMD3 (TMD3, ochre ﬁlled diamonds), or both TMD2 and TMD3 (TMD[2,3], brown ﬁlled
diamonds). (B) Additional comparisons with 3a mutants Y91A (purple ﬁlled diamonds), H93A (deep blue
ﬁlled triangles), Y109A (orange ﬁlled triangles), Y113A (brown ﬁlled triangles), or Q116A (red ﬁlled
diamonds) were performed. All mice were evaluated for weight loss (left) and survival (right) through 10
dpi. Data summarize two replicate experiments with equivalent results. Error bars represent the standard
deviations for mouse weight.
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The PBM of protein 3a was not required for SARS-CoV replication and viru-
lence. To analyze the requirement for the PBM of protein 3a for replication and
virulence, a virus lacking a functional PBM in the 3a protein (3aPBM) was engineered.
As ORF3a partially overlaps ORF3b, the protein 3a PBM core sequence (SVPL) was
disrupted with amino acid substitutions (GMSM), with codons carefully selected to
ensure that protein ORF3b was not mutated. Growth of the 3aPBM mutant in Vero E6
cells and in the lungs of infected mice was the same as that seen with rSARS-CoV-MA15
(Fig. 7A). Also, the 3aPBM mutant was as pathogenic as the parental virus (Fig. 7B).
These results indicated that, in the mouse model, replication and virus virulence were
independent of the PBM of protein 3a.
Simultaneous requirement of viroporins by SARS-CoV. In order to study the
interdependence of SARS-CoV viroporins, all possible combinations of single-, double-,
and triple-deletion mutants were engineered (Table 3). All combinations were efﬁ-
ciently rescued, with the remarkable exceptions of the triple mutant [rSARS-CoV-MA15-
Δ(3a,E,8a)] and the one lacking both E and 3a proteins [rSARS-CoV-MA15-Δ(3a,E)]. The
ΔE virus and double-deletion mutants Δ(3a,8a) and Δ(E,8a) showed signiﬁcantly re-
duced titers (1  106, 2  106, and 6  105 PFU/ml, respectively) compared to the Δ3a
and Δ8a mutants and the parental virus. Although a role for protein 8a was not
FIG 7 Requirement of the PBM of SARS-CoV 3a protein for replication and virulence. (A) (Left panel)
Subconﬂuent monolayers of Vero E6 cells were infected with wild-type (WT; black ﬁlled circles), Δ3a
(green ﬁlled circles), or 3a-PBM (red ﬁlled diamonds) SARS-CoV at a MOI of 0.001. Culture supernatants
collected at 4, 24, 48, and 72 hpi were titrated by plaque assay. Results are representative of three
replicate experiments. (Right panel) Groups of six 16-week-old BALB/c mice were infected with
100,000 PFU of the parental virus (WT, black columns) or of a SARS-CoV variant lacking the protein 3a
PBM (3a-PBM, red columns). At 2 and 4 dpi, 3 mice from each group were sacriﬁced to determine virus
titers. Data summarize two replicate experiments. Data represent means  SD. (B) Groups of ﬁve
16-week-old BALB/c mice were subjected to mock infection (PBS, gray ﬁlled squares) or infected with
100,000 PFU of the parental (wild-type) virus (WT; black ﬁlled hexagons) or of genetically engineered
mutants lacking the 3a protein (Δ3a, green ﬁlled circles) or lacking the protein 3a PBM (3a-PBM, red
ﬁlled diamonds). Mean levels of weight loss (left graph) and survival (right graph) through 10 dpi are
represented for each group. Data summarize two replicate experiments with equivalent results. Error bars
represent the standard deviations of mouse weight data.
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described for virus replication, the titers of viruses missing 8a and 3a or E were
signiﬁcantly lower than the titers of Δ3a and ΔE viruses. Also, every one of the viable
mutant viruses which lacked either 3a or E proteins showed plaque sizes that were
signiﬁcantly smaller than those seen with the wt and Δ8a viruses.
The results showed that at least either the 3a protein or the E protein must be
present for virus viability, which indicates that just one of these proteins could provide
the activities required for virus growth.
SARS-CoV 3a protein subcellular localization. To begin to understand the nature
of the replacement of E protein by 3a, or vice versa, in the replication of SARS-CoV, we
assessed the cellular localization of each protein. The SARS-CoV E protein localizes to
the ERGIC (56), but less is known about protein 3a localization (27). The potential
colocalization of the 3a and E proteins was ﬁrst studied by infecting Vero E6 cells with
wt rSARS-CoV. Confocal microscopy analysis of rSARS-CoV-MA15 at 24 hpi showed that
the proteins were located in different cell subcompartments during infection, as the
Pearson’s coefﬁcient value was below 0.6 (see Table S1 in the supplemental material)
(57); protein 3a mainly accumulated at an unidentiﬁed perinuclear compartment
different from the ERGIC (Fig. 8A). E protein IC activity promotes virulence by releasing
calcium from the ERGIC, leading to inﬂammasome activation (34, 58). We showed that
protein 3a IC activity is not involved in virus virulence. To extend these results, we next
determined whether 3a was localized to any of the known cellular calcium reservoirs,
i.e., the ER, the Golgi apparatus, and the mitochondria (59), using speciﬁc markers,
including protein disulﬁde isomerase (PDI) (ER marker), 58 K (Golgi marker), and
aconitase 2 (mitochondrion marker) (Fig. 8B). Also, other subcellular compartments
were analyzed for colocalization with the 3a protein by the use of antibodies (Abs)
against Na/K ATPase (plasma membrane marker), Rab5 (early endosome marker),
Rab7 (late endosome marker), and LAMP-1 (lysosome marker) (Fig. 9). Pearson’s coef-
ﬁcient was below 0.6 in all cases (Table S1). Overall, 3a protein did not localize at any
of the main intracellular calcium storage locations, suggesting that it is not located at
a site that facilitates increased cytosolic calcium levels. Collectively, these results
suggest that the IC activity of proteins 3a and E, while shared by the two proteins, is not
the function responsible for the replacement for the full-length E and 3a proteins.
Identiﬁcation of candidate motifs responsible for the replacement between E
and 3a proteins. To identify which E protein domain was essential in the absence of
full-length 3a protein, a set of Δ3a mutants was engineered with substitutions or
deletions throughout the E protein sequence (Fig. 10A), including (i) alanine substitu-
tions in the N-terminal domain [rSARS-CoV-MA15-(Δ3a,EΔ1)]; (ii) disruption of the TMD,
abrogating E protein IC activity [(Δ3a,E-N15A)] (34); (iii) short in-frame deletions
throughout the C-terminal domain [(Δ3a,EΔ2), (Δ3a,EΔ3), (Δ3a,EΔ4), (Δ3a,EΔ5), and
(Δ3a,EΔ6)]; (iv) truncation of E protein by the introduction of a stop codon 9 aa
upstream of the PBM [(Δ3a,E-ΔPBM)]; (v) interruption of the E protein PBM by amino
acid substitutions within its core sequence [(Δ3a,E-PBM)]; and (vi) replacement of the
E protein PBM with an alternative synthetic PBM sequence with proven binding to PDZ
domains (46) [(Δ3a,E-PBM*)]. The viability of each mutant was determined after rescue
TABLE 3 Simultaneous requirements of viroporins by SARS-CoV
Virus name
SARS-CoV viroporin
Viral titer (PFU/ml)3a E 8a
SARS-CoV wt    (4.0  1.2)  107
SARS-CoV Δ8a    (5.0  2.1)  107
SARS-CoV Δ3a    (1.0  1.9)  107
SARS-CoV ΔE    (1.0  0.8)  106
SARS-CoV Δ[E, 8a]    (6.6  1.4)  105
SARS-CoV Δ[3a, 8a]    (2.4  1.1)  106
SARS-CoV Δ[3a, E]    2.0  101a
SARS-CoV Δ[3a, E, 8a]    2.0  101a
aData were below the detection threshold.
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from infectious bacterial artiﬁcial chromosome (BAC) clones. For each mutant, two
independently generated BACs were analyzed (Fig. 10A). Mutations within the
N-terminal domain or TMD of protein E did not affect virus viability, indicating that
neither harbored the motif responsible for viroporin replacement. However, when the
protein E PBM was disrupted by amino acid substitutions [(Δ3a,E-PBM)], infectious
virus was not rescued. Consistent with this, when the original PBM was substituted for
an alternative one [(Δ3a,E-PBM*)], viable virus was recovered. Furthermore, the trun-
cated mutant [(Δ3a,E-ΔPBM)] rapidly reverted in the ﬁrst passage, losing the engineered
stop codon during passage in cell culture and regaining the PBM [Δ3a,E-ΔPBM(rev)].
Collectively, these data strongly support the idea of the requirement of the PBM for
FIG 8 Analysis of the subcellular localization of SARS-CoV 3a and E proteins by immunoﬂuorescence.
Vero E6 cells were grown on coverslips and infected with rSARS-CoV at a MOI of 0.3 and were
subsequently ﬁxed with 4% paraformaldehyde at 24 hpi. (A) Cells were labeled with antibodies speciﬁc
for 3a protein (green) or E protein (red). (B) Cells were labeled with antibodies speciﬁc for 3a protein
(shown in green) or for PDI (ER marker), 58 K (Golgi marker), or aconitase 2 (mitochondrion marker)
(shown in red). In all cases, nuclei were stained with DAPI (blue).
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viability of SARS-CoV (Fig. 10A) and indicate that it was the E protein with a functional
PBM that compensated for the loss of the full-length 3a protein. An additional mutant
was generated in which the protein 3a PBM was mutated in the context of full-length
E protein deletion [(3a-PBM,ΔE)], but the rescue of this virus was not possible
(Fig. 10B), again showing the necessity of at least one of the two proteins with a
functional PBM for virus viability in the context of complete deletion of either the E
gene or the 3a gene.
Also, virus titers were signiﬁcantly decreased after one passage for mutants Δ3a,EΔ1
and Δ3a,E-ΔPBM(rev) compared to the Δ3a virus (Fig. 10A). In addition, Δ3a viruses with
small deletions throughout the C terminus of E protein were not viable, possibly due
to the requirement of the 3a protein native structure or of a length essential for PBM
availability for binding to other viral or cellular proteins (Fig. 10A). To analyze the
relevance of protein shortening or folding, an additional mutant was constructed in the
Δ3a background by ﬁlling in the EΔ4 deletion with an alanine-rich sequence in order to
restore the original length or folding of the E protein [(Δ3a,EΔ4*)] (Fig. S2). This mutant
virus was viable, indicating the lack of sequence speciﬁcity for the observed function-
ality. An alternative role for other domains located in the middle of the E protein C
terminus cannot be completely ruled out.
FIG 9 Analysis of the subcellular localization of SARS-CoV 3a by immunoﬂuorescence. Vero E6 cells were
grown on coverslips and infected with rSARS-CoV at a MOI of 0.3 and were ﬁxed with 4% paraformaldehyde
at 24 hpi. Cells were labeled with antibodies speciﬁc for 3a protein (shown in green) or for Na/K ATPase
(plasma membrane marker), rab5 (early endosome marker), rab7 (late endosome marker), and lamp-1
(lysosome marker) (shown in red). In all cases, nuclei were stained with DAPI (blue).
SARS-CoV Viroporins in Replication and Pathogenesis ®
May/June 2018 Volume 9 Issue 3 e02325-17 mbio.asm.org 13
 o
n
 January 29, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
To further study replication dependence on the PBMs of E and 3a, a collection of
mutants with one [(3a-PBM) or (E-PBM)] or both [(3a,E]-PBM) viral PBM sequences
removed was generated (Fig. 10A). All three PBMmutants were viable, showing that the
consequences of the presence of E and 3a protein PBMs when these proteins have
been completely deleted are different from those seen when only their PBM is missing.
However, virus titers decreased 10-fold when both viral PBMs were missing in com-
parison to the levels seen with the parental virus or mutants lacking only one PBM
FIG 10 Mapping of the E protein domain required for the replacement of the 3a protein. (A) Viability of a set of SARS-CoV Δ3a mutants
with added mutations within the E gene was evaluated in Vero E6 cells. Changes to the E protein included the following: alanine
substitutions in the N-terminal domain [rSARS-CoV-MA15-(Δ3a,EΔ1)]; disruption of the TMD, abrogating E protein IC activity [(Δ3a,E-
N15A)]; short in-frame deletions throughout the C-terminal domain [(Δ3a,EΔ2), (Δ3a,EΔ3), (Δ3a,EΔ4), (Δ3a,EΔ5), and (Δ3a,EΔ6)]; truncation
of the E protein by introduction of a stop codon 6 aa upstream of the PBM [(Δ3a,E-ΔPBM)]; interruption of the E protein PBM by amino
acid substitutions within its core sequence [(Δ3a,E-PBM)]; and replacement of the E protein PBM with an alternative PBM sequence
[(Δ3a,E-PBM*)]. The ΔPBM(rev) sequence represents the sequence of a spontaneous revertant virus isolated after growth of the original
ΔPBM strain in cell culture. (B) Viability of SARS-CoV ΔE mutants with or without 3a protein PBM was evaluated in Vero E6 cells. Titers of
the viable viruses after the ﬁrst passage (representative of three replicate experiments) are shown. Data represent means  SD. NR, not
rescued.
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(Fig. 11A). Remarkably, when PBM was present in E protein, the virus was highly virulent
independently of whether the 3a protein included a PBM (Fig. 11B). In contrast,
mortality signiﬁcantly decreased when E protein lacked a PBM, regardless of the
presence or absence of a PBM within protein 3a. These results indicated that the impact
of the presence or absence of the E protein PBM on virulence is deﬁnitive, as it
determines whether a virus is pathogenic or nonpathogenic, respectively. In contrast,
the presence or absence of 3a protein with or without its PBM had little impact on virus
virulence, illustrating the much greater relevance of the E protein PBM than of the 3a
PBM with respect to virus pathogenicity.
DISCUSSION
Viroporins are highly relevant for viral replication and pathogenesis, and their
requirement in a large number of physiological processes makes their study a ﬁeld of
growing interest (17, 18, 23). CoVs usually encode two or more viroporins, including the
conserved structural E protein and additional ones encoded by accessory genes. The
roles of these viroporins in replication and virulence had been studied in detail only for
SARS-CoV E protein (34, 46, 58, 60), though roles in replication have also been
FIG 11 Virulence of recombinant SARS-CoV combining the knockdown of 3a and E protein PBMs. (A) Schematic
of recombinant mutants with knockdown of the PBMs of the 3a and E proteins in different combinations. Titers of
the viable viruses (representative of three replicate experiments) are shown. Data represent means  SD. (B)
Groups of ﬁve 16-week-old BALB/c mice were subjected to mock infection (PBS, gray ﬁlled squares) or infected with
100,000 PFU of the parental (wild-type) virus (WT; black ﬁlled hexagons) or of genetically engineered viruses lacking
either the protein 3a PBM (3a-PBM, red ﬁlled diamonds) or the E protein PBM (E-PBM, ochre ﬁlled circles) or both
[(3a,E)-PBM, green ﬁlled circles]. Mean levels of weight loss (left) and survival (right) through 10 dpi are
represented for each group. Data summarize two replicate experiments with equivalent results. Error bars represent
the standard deviations of mouse weight data.
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established for HCoV-OC43 ns12.9 (25), HCoV-229E 4a (24), and PEDV 3 (26). MERS-CoV
encodes two proteins, E and 5, homologues of the SARS-CoV E and 3a proteins,
respectively. While the IC activity of MERS-CoV E protein has been previously described
(15), the potential IC activity of protein 5 is yet to be studied in detail. However, due to
its similarity to SARS-CoV 3a, HCoV-229E 4a, and PEDV 3, IC conductance by this protein
is expected. Furthermore, both the MERS-CoV E and 5 proteins have a putative PBM at
their carboxy terminus, similarly to the SARS-CoV E and 3a proteins.
SARS-CoV encodes three viroporins: 3a, E, and 8a (14, 27, 28). We have previously
shown that a SARS-CoV mutant lacking E protein was attenuated in mice (61). Here, we
show that removal of the 3a protein slightly reduced virus titers in vitro compared to
the results seen with the parental virus (Fig. 1A). In contrast, the titers of the Δ3a mutant
were reduced 10-fold in vivo (Fig. 1B), indicating that the 3a protein was required for
optimal SARS-CoV replication. This result is in agreement with previous studies showing
a slight reduction of SARS-CoV-Δ3a titers in Vero E6 cells (62). Nevertheless, it has to be
noted that the mice in the previous study were infected with a human SARS-CoV Urbani
strain, which causes only a mild murine infection, in contrast to our mouse-adapted
strain (61). The reduction of titers after infection with Δ3a mutant viruses may reﬂect
the role of 3a in membrane rearrangement, increasing the levels of intracellular vesicles
that can promote nonlytic release of viral particles (30). Alternatively, protein 3a may
induce apoptosis (30, 63) and may enhance inﬂammation by activating nuclear factor
kappa B (NF-kB), leading to the production of proinﬂammatory cytokines such as
interleukin-8 (IL-8) and RANTES (CCL5) (29). In fact, histopathological analysis of lungs
from SARS-CoV-Δ3a-infected mice showed minimal damage or cellular inﬁltration at 2
and 4 dpi, whereas mice infected with the SARS-CoV parental virus revealed interstitial
and peribronchial cell inﬁltration and edema in both alveolar and bronchiolar airways
at 2 dpi and, mainly, at 4 dpi (see Fig. S3 in the supplemental material). This suggests
that the attenuation of the Δ3a mutant may be due to its inability to activate an
exacerbated proinﬂammatory response, resulting in survival of infected mice. In fact,
similar results were obtained in the lungs of mice infected with rSARS-CoV-MA15-ΔE,
which also led to attenuation by downregulation of the host proinﬂammatory response
(61, 64).
We showed that deletion of SARS-CoV protein 8a alone did not have a measurable
effect on replication and virulence in mice (Fig. 1 and 2). This is in line with the fact that
ORF8 was lost during the SARS-CoV pandemic and that viruses lacking this gene were
recovered from patients who died from SARS-CoV infection, supporting the idea that it
is also not required for virulence in humans (65). However, viruses lacking 8a protein
when 3a protein was also deleted had titers 10-fold lower than those seen with the
parental virus, indicating that simultaneous deletion of the two proteins may contribute
to replication to at least a small extent.
Residues involved in E protein IC activity have been previously identiﬁed (33), and
this activity was essential for replication and virulence (34). We previously reported that
the E ion channel activates the inﬂammasome through calcium release from intracel-
lular stores (34, 58). IC activity of SARS-CoV E protein is exerted in the membrane of the
ERGIC. This facilitates the release of Ca2 from this intracellular compartment, which
contributes to the activation of the inﬂammasome complex, leading to the release of
proinﬂammatory cytokines such as tumor necrosis factor alpha (TNF-), IL-1, and IL-6.
The accumulation of these cytokines promotes an exacerbated proinﬂammatory re-
sponse, which leads to death. Thus, E protein IC activity is a virulence factor similar to
the IC activities of M2 from inﬂuenza virus (19) or rotavirus NSP4 (13, 66). As E protein
IC activity promotes virulence via inﬂammasome activation (34, 58), we hypothesized
that protein 3a IC activity could act in a similar way. However, as no correlation was
found between protein 3a IC activity and SARS-CoV titer and pathogenicity, we
conclude that, in our mouse model, the IC activity of 3a protein did not affect
replication and virulence in the same way as that of E protein. However, SARS-CoV 3a
protein TMD3 and TMD[2,3] mutants displayed no IC activity and were attenuated.
In principle, a possible explanation for this observation is that the TMD3 three-amino-
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acid mutations present in both mutant TMD3 and mutant TMD[2,3] could have
disrupted a function of the 3a protein other than its IC activity. Nevertheless, viruses
that included the point mutations that disrupt IC activity (Y91A, H93A, and Y109A) and
which are less likely to affect other functions of the 3a protein than the 3-amino-acid
and 5-amino-acid mutations of TMD3 and TMD[2,3], respectively, were completely
virulent. The TMD3 mutant showed 10-fold-lower titers in the lungs of infected mice.
The impact of these mutants on virus replication and virulence may in principle be due
to an exclusive effect on 3a protein functions different from its IC activity. The
TMD[2,3] mutant maintained the same titers as the native virus, which could be
explained if the mutations in TMD2 were structurally compensated for the ones in
TMD3 when the two were simultaneously present in protein 3a. Overall, these results
indicate that protein 3a IC activity is not involved in virus virulence.
There are several factors that may account for the differences in the degrees of
relevance of the SARS-CoV E and protein 3a IC activities. The two proteins localize to
different subcellular compartments (Fig. 8A), suggesting that the IC activity of the two
proteins regulates ion transport between different compartments. E protein locates in
the ERGIC (56) and induces calcium efﬂux during SARS-CoV infection, which activates
the inﬂammasome complex, leading to the acute proinﬂammatory response associated
with virus pathogenicity (34, 58). As protein 3a is not found at any of the main
intracellular Ca2 storage locations (Fig. 8B), its IC activity most likely induces cellular
pathways that are less relevant to pathogenesis.
Note that SARS-CoV 3a protein subcellular localization had been previously studied
by transfecting cells with a plasmid, which overexpresses a tagged variant of 3a protein,
leading to the conclusion that protein 3a is located at the Golgi compartment or at
the cell surface (31, 67). These studies have also been performed in the context of the
infection but without the use of subcellular compartment markers, leading to the
observation that protein 3a was located in the cell membrane, in the cytoplasm, and in
the nucleus (27). After our analysis in the context of the infection using markers for
cellular compartments, we could not conclude that the SARS-CoV 3a protein is located
in any of the previously described compartments. Furthermore, knowledge of the
cellular location in which the 3a protein accumulates remained elusive after our analysis
performed using markers for the following different intracellular compartments: ER,
Golgi apparatus, mitochondria, early and late endosomes, lysosomes, and the plasma
membrane.
The E protein PBM is another virulence factor of SARS-CoV (46), with a homologous
motif present in protein 3a. However, analysis of mutants lacking the 3a PBM showed
no effect on virus production or virulence (Fig. 7). The requirement for protein E with
its PBM was dominant for SARS-CoV virulence in comparison to the requirement for
protein 3a with its PBM (Fig. 11). Furthermore, a SARS-CoV with E protein that included
its PBM was virulent in the presence or absence of 3a protein PBM, whereas in the
reverse situation (the presence of 3a protein with its PBM and of E protein lacking its
PBM), the virus was always attenuated, reinforcing the idea of the dominance of the E
protein PBM for virus pathogenicity over that of 3a protein.
The interaction of the E protein PBM with syntenin PDZ motifs activates the p38
mitogen-activated protein kinase (MAPK) pathway and promotes an acute proinﬂam-
matory response that leads to death (46). However, other viral PBMs likely show a
preference for distinct PDZ domains. There are 266 motifs present in more than 400
cellular protein isoforms, each containing between 1 and 13 PDZ domains (42). As
SARS-CoV E and 3a protein PBM sequences are different (DLLV and SVPL, respectively),
they are likely to interact with different networks of PDZ-containing cellular proteins.
The protein 3a PBM interaction with cellular PDZ proteins most likely induces a
signaling pathway that either is not pathogenic for the host or is activated at a lower
intensity due to a reduced afﬁnity of the viral PBM for the cellular PDZ domain,
explaining why viruses with or without the PBM of 3a showed no signiﬁcant differences
in pathogenicity. However, given that the protein 3a PBM is required for virus viability
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when full-length E protein is missing, it can be conﬁrmed that the pathways activated
by the protein 3a PBM have some impact on virus replication.
In order to study the interdependence of the SARS-CoV viroporins, the effects of
deletion of one viroporin or of simultaneous deletions of two or three viroporins were
determined. The 8a protein was included to determine its potential relevance in the
absence of the other viroporins, showing a signiﬁcant impact on viral growth under
conditions in which 3a protein or E protein was absent. In contrast, we observed that
SARS-CoV was not viable when both the 3a and E proteins were absent but that its
viability was rescued by the presence of either 3a or E. We showed that the E protein
could compensate for the loss of the other viroporin providing that it carried a
functional PBM (Fig. 10A), a conclusion reinforced by the results obtained with ﬁve
different recombinant viruses. Even more biologically relevant was the rapid reversion
of a stop codon introduced 9 aa upstream of the carboxy terminus of the E protein in
mutant ΔPBM. Reversion was identiﬁed only in this mutant, presumably because
reversion of a single altered codon occurs more easily than the 4-aa changes in E-PBM
or the deletions performed (Fig. 10A). Our results also showed that a 3a protein carrying
a PBM could compensate for the loss of E protein and could restore virus replication but
not virulence (Fig. 10B and 11).
The idea of the requirement of SARS-CoV PBMs for virus replication and virulence is
also supported by our previous observations revealing that ΔE mutants evolved to
introduce a new transmembrane protein with a PBM to compensate for the loss of the
whole E protein during passage either in cell culture or in vivo (68). In addition, when
SARS-CoV-ΔE was passaged in mice, it spontaneously gained an internal PBM in the 8a
protein. PBMs are also phylogenetically conserved in proteins from SARS-CoV and
MERS-CoV isolates from humans, civet cats, dromedary camels, and bats (Fig. S4),
further reinforcing the idea of the relevance of PBMs for coronavirus viability. Viral
PBM-cellular PDZ interactions have been previously described in several viruses. For
instance, the PBM of E6 oncoprotein from human papillomavirus 16 (HPV-16) interacts
with several cellular proteins containing PDZ motifs, leading to tumorigenesis and virus
dissemination (69). On the other hand, different strains of rabies virus (RABV) include a
variety of PBMs in the G protein that differentially contribute to viral virulence through
activation of a variety of signaling pathways (70). In the case of inﬂuenza virus, NS1
protein has a PBM located at its carboxy terminus that is possibly involved in enhanced
virulence (71). In addition, the vaccinia virus F11 protein has both a PDZ domain and
a PBM, which inﬂuence viral spread (72).
Overall, we conclude that the SARS-CoV E and 3a proteins have in common two
important characteristics: IC activity and PBM. Both the IC and the PBM of E protein are
involved in SARS-CoV virulence and replication, whereas the corresponding motifs in
protein 3a are not. We showed a dominance of E protein PBM and IC activities over that
of the 3a protein homologues. However, the protein 3a PBM became relevant for virus
viability in the absence of full-length E protein. These results contribute to a better
understanding of the role of CoV IC activities and PBMs, with impacts on the rational
design of future vaccines and antivirals.
MATERIALS AND METHODS
Ethics statement. Animal experimental protocols were approved by the Ethical Committee of the
Center for Animal Health Research (CISA-INIA) (permit numbers 2011-009 and 2011-09) in strict accor-
dance with Spanish National Royal Decree (RD 53/2013) and international EU guidelines 2010/2063/UE
and Spanish national law 32/2007. Infected mice were housed in a self-contained ventilated rack
(Allentown, NJ).
Viruses. Mouse-adapted (MA15) (48) parental wild-type (wt) and recombinant viruses were rescued
from infectious cDNA clones generated in a bacterial artiﬁcial chromosome (BAC) (49, 73–75).
Generation of recombinant viruses. Viruses with mutations in SARS-CoV viroporins E, 3a, and 8a
were constructed in an infectious cDNA clone of SARS-CoV-MA15 within a bacterial artiﬁcial chromosome
(BAC) (plasmid pBAC-SARS-CoV-MA15) (49, 73, 76). Generation of the E deletion mutant was described
previously (61). The 3a gene was deleted by overlap extension PCR using pBAC-SARS-CoV-MA15 and the
primers shown in Table S2 in the supplemental material. Mutations included deletion of a region
(nt 25270 to 25668) of the SARS-CoV genome, resulting in deletion of the 3a protein while retaining the
3b protein; a disruption of the ATG start codon of the 3a gene; and point mutations at nt 25673 and
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25683 to introduce two stop codons and a point mutation at nt 26042 to disrupt a potential initiation
codon. A PCR product was generated from nt 24937 to 26060 of the SARS-CoV genome, digested at
ﬂanking SwaI and BamHI sites, and cloned into intermediate plasmid pBAC-SARS-PmeI-BamHI-SARS-CoV
(which contains the nt-18404-to-26044 sequence of the SARS-CoV infectious cDNA clone) to generate
plasmid pBAC-SARS-PmeI-BamHI-Δ3a. Finally, that plasmid was digested with PmeI and BamHI and the
fragment carrying the 3a deletion was reinserted into a similarly digested pBAC-SARS-CoV-MA15 plasmid
to generate pBAC-SARS-CoV-Δ3a. To construct the 8a deletion mutant, a DNA fragment containing
nt 26790 to 28753 of the SARS-CoV genome ﬂanked by restriction sites XcmI and NheI was assembled
by overlap extension PCR using pBAC-SARS-CoV-MA15 as the template and the primers indicated in
Table S1; this process resulted in the deletion of the ﬁrst 82 nt of the 8a gene without affecting the 8b
gene. The ﬁnal PCR products were digested with XcmI and NheI and cloned into intermediate plasmid
pBAC-BamHI-RsrII-SARS-CoV (which contains nt 26044 to 29782 of the SARS-CoV infectious cDNA clone
[49]), thus obtaining pBAC-BamHI-RsrII-SARS-CoV-Δ8a. That plasmid was digested with BamHI and RsrII,
and the fragment carrying the deletion of the 8a gene was reinserted into pBAC-SARS-CoV-MA15,
generating pBAC-SARS-CoV-Δ8a.
To generate mutants with mutations in the 3a IC, DNA fragments containing nt 25016 to 26044 of
the SARS-CoV genome were produced by overlap extension PCR using plasmid pBAC-SARS-CoV-MA15 as
a template and the primers indicated in Table S1. The following mutations were introduced: S40A (TCA
to GCA), S48A (AGC to GCC), Y91A (TAT to GCT), H93A (CAT to GCT), Y109A (TAT to GCT), Y113A (TAT to
GCT), Q116A (CAA to GCA), TMD1 (including both S40A and S48A), TMD2 (including both Y91A and
H93A), TMD3 (including Y109A, Y113A, and Q116A), and TMD[2,3] (including Y91A, H93A, Y109A,
Y113A, and Q116A). The PCR products were digested at ﬂanking SwaI and BamHI sites and cloned into
pBAC-PmeI-BamHI-SARS-CoV (49). Intermediate plasmids were digested with PmeI and BamHI and
recloned into pBAC-SARS-CoV-MA15 to generate infectious SARS-CoV cDNA clones for each mutation. To
mutate the PBM sequence of 3a, overlap extension PCR was performed using pBAC-SARS-CoV-MA15 as
the template and the primers indicated in Table S2, resulting in a DNA fragment containing nt 26044 to
26790 of the SARS-CoV genome. The core 3a PBM (SVPL; nt AGCGTGCCTTTG), was replaced with an
alternative sequence (GMSM; nt GGCATGTCTATG). As the 3a and 3b genes overlap in this region, care
was taken to introduce only silent mutations into the 3b ORF. The resulting PCR fragment was digested
at ﬂanking BamHI and XcmI sites and cloned into intermediate plasmid pBAC-BamHI-RsrII-SARS-CoV (49),
resulting in pBAC-BamHI-RsrII-SARS-CoV-3amutPBM. This plasmid was digested with BamHI and RsrII, and
the fragment carrying the mutated 3a PBM was reinserted into pBAC-SARS-CoV-MA15 to generate
plasmid pBAC-SARS-CoV-3a-PBM.
Viruses combining deletion of the 3a gene with mutations throughout the E gene were generated
by digesting previously described plasmids pBAC-SARS-CoV-MA15-EΔ1, -EΔ2, -EΔ3, -EΔ4, -EΔ5, and -EΔ6
(75) and -E-PBM and -E-PBM* (46) with BamHI and RsrII and cloning the fragments with mutations into
a similarly digested pBAC-SARS-CoV-MA15-Δ3a plasmid.
In order to generate recombinant baculoviruses for 3a protein (rBV-3a), all constructs of the SARS-CoV
3a gene were cloned into a pFastBac vector (Invitrogen) containing a tobacco etch virus (TEV) cleavable
site and 10 histidine residues fused to the C terminus of the 3a constructs. Recombinant baculoviruses
were produced following the instructions of the manufacturer (Invitrogen).
Recovery of recombinant SARS-CoV variants from the cDNA clones. BHK cells were grown to 95%
conﬂuence in 12.5-cm2 ﬂasks and transfected with 6 g of infectious cDNA clone and 18 l of
Lipofectamine 2000 (Invitrogen), according to the manufacturer’s speciﬁcations. At 6 h posttransfection
(hpt), cells were trypsinized, added to conﬂuent Vero E6 cells monolayers grown in 12.5-cm2 ﬂasks, and
incubated at 37°C for 72 h. Cell supernatants were harvested and passaged once on fresh cells, and the
recovered viruses were cloned by three rounds of plaque puriﬁcation following standard procedures.
Cells. Vero E6 cells and BHK cells were kindly provided by E. Snijder (University of Leiden, the
Netherlands) and H. Laude (Unité de Virologie et Immunologie Molecularies, INRA, France), respectively.
In all cases, cells were grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Gibco) supplemented with
25 mM HEPES, 2 mM L-glutamine (Sigma), 1% nonessential amino acids (Sigma), and 10% fetal bovine
serum (FBS; BioWhittaker, Inc.). Virus titrations were performed in Vero E6 cells as previously described
(61).
Mice. Eight-week-old speciﬁc-pathogen-free BALB/c Ola Hsd female mice were purchased from
Harlan Laboratories and maintained for 8 additional weeks in the animal care facility at the National
Center of Biotechnology (Madrid). For infection experiments, mice were anesthetized with isoﬂurane and
intranasally inoculated at 16 weeks of age with 100,000 PFU of the indicated viruses. All work with
infected animals was performed in a biosafety level 3 (BSL3) laboratory (CISA, INIA) by technicians
wearing personal protection equipment (3M).
Generation of polyclonal antibodies speciﬁc for the SARS-CoV 3a protein. A synthetic peptide
corresponding to residues 11 to 24 of the SARS-CoV 3a protein (C-ESITAQPVKIDNAS) was generated and
used to immunize two rabbits (Biogenes, Berlin, Germany) according to the standard protocol of the
supplier. Serums were collected at 45 dpi and evaluated by enzyme-linked immunosorbent assay (ELISA)
and immunoﬂuorescence and Western blot analysis using Vero E6 cells infected with SARS-CoV-wt or
SARS-CoV-Δ3a as a negative control.
Virus genome sequencing. Regions of the SARS-CoV genome corresponding to the 3a, E, and 8a
genes were sequenced after reverse transcriptase PCR (RT-PCR). Brieﬂy, total RNA from infected cells or
homogenized mouse lungs was collected and puriﬁed using an RNeasy kit (Qiagen) according to the
manufacturer’s speciﬁcations. For RT reactions, 100 ng of RNA, random oligonucleotide primers, and
ThermoScript reverse transcriptase (Invitrogen) were used. RT products were subsequently subjected to
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PCR using Vent polymerase (New England Biolabs) and the following primer pairs: 24937-VS (GGCGAC
ATTTCAGGCATTAACGC) and 26086-RS (GGCACGCTAGTAGTCGTCGTCGGC), which amplify the 3a gene;
E-VS (CTCTTCAGGAGTTGCTAATCCAGCAATGG) and E-RS (TCCAGGAGTTGTTTAAGCTTCTCAACGGTA),
which amplify nucleotides 26017 to 26447, including the E gene; and 27545-VS (GGAGGTTCAACAAGA
GCTCTACTCGCC) and 28008-RS (GACAGTTGATAGTAACATTAGGTGTGC), amplifying a region that includes
the 8a gene. Sequence assembly and comparison with the parent consensus sequence were performed
with SeqMan software (Lasergene, Madison, WI).
Growth kinetics. Subconﬂuent monolayers (90% conﬂuence) of Vero E6 cells in 12.5-cm2 ﬂasks were
infected at a multiplicity of infection (MOI) of 0.001 with the indicated viruses. Culture supernatants were
collected at 0, 4, 24, 48, and 72 h postinfection (hpi), and virus titers were determined as previously
described (61). For the analysis of cell-associated virus, Vero E6 cells were infected at a MOI of 0.001 with
the indicated viruses. At 24 and 48 hpi, cells were recovered in phosphate-buffered saline (PBS) buffer
and disrupted by four freeze-thaw cycles. Samples were then centrifuged to remove cell debris, and
supernatants were titrated as previously described (59).
Virus infection and growth in mice. BALB/c mice were anesthetized with isoﬂurane and intranasally
inoculated with 100,000 PFU of virus mixed with 50 l of DMEM. Weight loss and mortality were
evaluated daily. To determine SARS-CoV titers, lungs were homogenized in PBS containing 100 IU/ml
penicillin, 0.1 mg/ml streptomycin, 50 g/ml gentamicin, and 0.5 g/ml amphotericin B (Fungizone),
using a gentleMACS dissociator (Miltenyi Biotec, Inc.). Virus titrations were performed in Vero E6 cells as
previously described (61). Viral titers were expressed as PFU counts per gram of tissue.
Histopathology.Mice were sacriﬁced at 2 and 4 dpi. Lungs were removed, ﬁxed in zinc formalin, and
embedded in parafﬁn. Histopathological examinations were performed on sections stained with
hematoxylin-eosin.
Ion channel reconstitution and ionic current recording. Planar bilayers were formed by apposition
of two monolayers prepared from a mixture of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-
dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(DOPE) at a DOPC/DOPS/DOPE ratio of 3:1:1 (wt/wt) (Avanti Polar Lipids, Alabaster, AL) mixed in pentane
at 5 mg/ml. Lipids were added on ~100-m-diameter oriﬁces in the 15-m-thick Teﬂon partition that
separated two identical chambers (50, 77); the oriﬁces were pretreated with a 1% solution of hexade-
cane–pentane. Aqueous solutions of KCl, NaCl, or CaCl2 were buffered with 5 mM HEPES at pH 6. All
measurements were performed at room temperature (23  1°C). Ion channel insertion was achieved by
adding 0.5 to 1 l of a 300 g/ml solution of recombinant protein in a buffer containing acetonitrile-
isopropanol (40:60) on one side of the chamber (here referred to as the cis side).
An electric potential was applied using Ag/AgCl electrodes in 2 M KCl–1.5% agarose bridges
assembled within standard 250-l pipette tips. The potential was deﬁned as positive when it was higher
on the cis side, whereas the trans side was set to ground. An Axopatch 200B ampliﬁer (Molecular Devices,
Sunnyvale, CA) was used in the voltage-clamp mode to measure the current and the applied potential.
The chamber and the head stage were isolated from external noise sources with a double metal screen
(Amuneal Manufacturing Corp., Philadelphia, PA). Single-channel conductance data were obtained from
current measurements under conditions of an applied potential of 100 mV and were evaluated using
the Gaussian ﬁt tool of Sigma plot 12 (Systat Software, Inc.).
The reversal potential, Erev, was determined as follows. First, a lipid membrane was formed at a given
salt concentration gradient. Second, one or several channels were inserted into the bilayer and a net ionic
current appeared due to the concentration gradient. Third, the ionic current through the channel or
channels was manually set to zero by adjusting the applied potential. The potential needed to achieve
zero current was then corrected using values corresponding to the liquid junction potentials of the
electrode salt bridges (78) to obtain the ﬁnal Erev.
Confocal microscopy. Vero E6 cells were grown to 90% conﬂuence on glass coverslips and infected
with wt SARS-CoV at a MOI of 0.3 PFU/cell. At 24 hpi, the medium was removed and cells were washed
twice with PBS and ﬁxed with 4% paraformaldehyde–PBS for 30 min at room temperature. Cells were
subsequently washed twice with PBS, permeabilized for 10 min with ice-cold methanol, and then blocked
with PBS containing 10% FBS for 40 min at room temperature. Immunoﬂuorescence was performed
using mouse Abs speciﬁc for SARS-CoV E protein (generated as described in reference 56) (1:500), protein
disulﬁde isomerase (PDI; Abcam, Inc.) (1:500), 58 K (Abcam, Inc.) (1:100), aconitase 2 (Abcam, Inc.) (1:500),
rab5 (BD Biosciences) (1:100), rab7 (BD Biosciences) (1:100), lamp-1 (Santa Cruz Biotechnologies) (1:50),
and Na/K ATPase (Santa Cruz Biotechnologies) (1:50) and rabbit Abs speciﬁc for SARS-CoV 3a protein
(1:500). Primary antibodies were diluted in PBS containing 5% FBS and incubated for 90 min at room
temperature, and then coverslips were washed four times with PBS before incubation with secondary
antibodies was performed. Alexa 488- or Alexa 546-conjugated antibodies speciﬁc for the different
species (Invitrogen) were diluted 1:500 in PBS containing 5% FBS and incubated for 45 min at room
temperature. Nuclei were stained using DAPI (4=,6-diamidino-2-phenylindole; Sigma) (1:200), and cov-
erslips were mounted in ProLong Gold anti-fade reagent (Invitrogen) and examined on a Leica SP5
confocal microscope (Leica Microsystems, Inc.). Image analysis was performed using ImageJ (79) and the
JACoP plug-in (57). Three areas per image of 120 by 120 pixels with high accumulation of 3a protein were
analyzed to determine Pearson’s coefﬁcient (Pc). Pc values below 0.6 were considered negative for
colocalization. Partial colocalization was considered to have occurred for Pc values between 0.6 and 0.85.
Pc values between 0.85 and 1 were considered positive for colocalization.
Production and puriﬁcation of SARS-CoV 3a protein and its mutant variants from a recombi-
nant baculovirus (rBV-3a). H5 cells at 80% conﬂuence were infected (MOI 1) with rBV-3a (constructed
as speciﬁed in the “Generation of recombinant viruses” section above) and incubated at 22°C for 72 h.
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Cells were harvested and resuspended in lysis buffer 1 (50 mM Tris-HCl, 300 mM NaCl, 0.5% Triton X-100,
pH 7.5) supplemented with 1% protease inhibitor cocktail (Sigma). Protein extracts were centrifuged at
12,000 g for 10 min at 4°C, and the pellets were resuspended in lysis buffer 2 (8 M urea, 50 mM Tris-HCl,
300 mM NaCl, 1% IGEPAL, 1 mM -mercaptoethanol, 10 mM imidazole, pH 7.5). Each sample was
sonicated three times for 20 s each time and centrifuged at 12,000  g for 10 min at 4°C. Finally, the
protein present in the supernatant was puriﬁed through metal afﬁnity chromatography (IMAC) using
cobalt resin (Clontech) following the manufacturer’s instructions. Every fraction from the puriﬁcation
process was analyzed in 12% polyacrylamide gels using Coomassie Blue EZBlue gel staining reagent
(Sigma). Then, the obtained protein was desalted using a PD-10 desalting column (GE Healthcare) and
eluted in PBS.
Statistical analysis. Two-tailed, unpaired Student’s t tests were used to analyze the differences in
mean values between groups. All results were expressed as means  standard deviations; P values of
0.1 were considered signiﬁcant.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.02325-17.
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